ARCHIVES

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

OMB Restriction On Reprogramming Threatens Grants Of Three Centers, Possible Restorations

June 6, 1986

NCI Plans Conference To Reconsider Breast Cancer Screening In women 40-49

April 19, 1996

Wittes, Fraumeni Appointed As Division Directors

February 9, 1996

Organ Site Grants Fare Badly In NIH Study Section Review; RPMI, UT Galveston, Rush Compete For HQ

October 21, 1983

Reinventing NCI: Prevention Program Lacks Leadership, Reorganization Needed, Advisory Group Says

June 20, 1997

AACR, Kellogg’s Co. Sponsor Award

January 5, 1996